MGI News

MGI News

AllLatest NewsEvents & Campaigns
MGI HQ

Future Of Omics 2025

MGI Tech Empowers the University of Lisbon to Study Impact of Saharan Dust on Portuguese Agriculture

MGI Tech Empowers the University of Lisbon to Study Impact of Saharan Dust on Portuguese Agriculture -Vineyards as Key Case Study

As Rare Disease Day approaches, NeoGenomica partnered with MGI Tech to advance rare disease diagnosis. João Bosco and Victor Camillo, Sales Director at MGI Tech Brazil, explained that the collaboration establishes scalable and equitable frameworks, using MGI’s advanced sequencing platforms to accelerate genomic testing and support timely, accurate clinical decisions for patients.

Brazil’s Next Chapter in Genomic Medicine: Scaling Whole-Genome Sequencing to Transform Rare Disease Diagnosis

Analytica 2026

MGI Tech Brings High-Throughput T7+ Sequencer to European Market at Analytica 2026 Debut

Benchmarking study shows MGI DNBSEQ platforms deliver superior sequencing quality, alignment performance and variant calling accuracy at 30× coverage.

DNBSEQ Platforms Demonstrate Superior Performance in Cross-Platform Benchmarking Study

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

Advancing Spatial Multi-Omics with STOmics

MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions

MGI SZN

MGI Tech Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research

China HQ

Case Study: MGI’s Single-Cell Technology Driving Breakthroughs in Metabolic Disease Research

MGI partners with Prepaire Labs at MEDLAB Middle East 2024

MGI Tech Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

MGI Tech and Dante Labs

MGI Tech Announces Partnership with Dante Genomics for Further Expansion in the Middle East Region

Prof. Yannis Pitsiladis and his team discuss in the smart laboratory powered by MGI's technology

MGI Tech Empowers CESAME to Advance Anti-Doping Testing through Transcriptomics and Multi-Omics Sequencing